Alimera Sciences (ALIM) 2018-05-04T15:34:19+00:00

Alimera Sciences (ALIM)

Alimera Sciences (ALIM) is a pharmaceutical company that develops and commercializes ophthalmic pharmaceuticals in the US & internationally that are focused on the back of the eye or retina. The company’s lead product is Iluvien, a 3 year intravitreal implant for the treatment of diabetic macular edema (DME), a disease of the retina that affects individuals with diabetes and could lead to severe vision loss and blindness.